Illustration of a clinic building (not a photo of the practice)
Illustration

Mark Charbonnet, MD

General Practice in New Iberia, LA

  • Enrolled in Medicare
  • Accepts Medicare assignment
  • 30 years since graduation
  • Public record — not managed by the clinician

About Dr. Mark Charbonnet

Dr. Mark Charbonnet is a physician specializing in general practice practicing in New Iberia, LA, a graduate of Louisiana State University School of Medicine in New Orleans (1996). Affiliated with Abbeville General Hospital, Fmol Health Our Lady of Lourdes, Iberia Medical Center. Treated 310 Medicare patients in 2024.

Provider details

SpecialtyGeneral PracticeOther general practice doctors in New Iberia
Also practicesMedical Oncology
CredentialsMD
EducationLouisiana State University School of Medicine in New Orleans, 1996CMS Doctors and Clinicians
GenderMale
NPI number1891718177National Provider Identifier (CMS NPPES), issued July 2006
MedicareEnrolled in Medicare; accepts Medicare assignment (the Medicare-approved amount as full payment)CMS Doctors and Clinicians

Dr. Mark Charbonnet's specialties and state licenses

  • Hematology & Oncology Primary
    License: LA 023042

As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.

Where Dr. Mark Charbonnet practices

  • Practice address 602 N Lewis St, Suite 600, New Iberia, LA 70563 Directions

Addresses from CMS Doctors and Clinicians (Medicare enrollment). Call before visiting: a clinician may not see patients at every listed address.

Hospital affiliations of Dr. Mark Charbonnet

  • Abbeville General HospitalHospital · Abbeville, LA
  • Fmol Health Our Lady of LourdesHospital · Lafayette, LA
  • Iberia Medical CenterHospital · New Iberia, LA

CMS Facility Affiliation data: facilities where the clinician bills Medicare.

Dr. Mark Charbonnet's Medicare quality score (MIPS 2024)

75/100final MIPS score

The Merit-based Incentive Payment System scores clinicians who bill Medicare. Reported as individual. Source: CMS Care Compare, PY 2024 clinician public reporting.

Dr. Mark Charbonnet's Medicare patients and services (2024)

310Medicare patients
69,267services billed
76average patient age
81%women

Most frequent services

ServiceTimesAvg. Medicare allowed
Injection of drug or substance under skin or into muscle1,687$13
Injection of additional new drug or substance into vein999$13.39
Insertion of needle into vein for collection of blood sample655$8.47
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count591$7.43
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more589$83.57
Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more563$51.62
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour532$17.98
Unclassified drugs455$2.64

Common conditions among these patients

  • High cholesterol75%
  • High blood pressure75%
  • Osteoporosis64%
  • Arthritis49%
  • Ischemic heart disease32%
  • Anxiety disorders30%

Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.

Payments from drug and device companies to Dr. Mark Charbonnet (2025)

$2,624.37 in 29 general payments reported in 2025.

TypePaymentsAmount
Consulting fees2$1,675
Food and beverage27$949.37

Paying companies: AstraZeneca Pharmaceuticals LP ($1,841.76), Janssen Biotech, Inc. ($182.37), Incyte Corporation ($100.62), ASD Specialty Healthcare, LLC ($98.77), Bayer HealthCare Pharmaceuticals Inc. ($75.45), SpringWorks Therapeutics, Inc. ($72.04).

Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.

Questions about Dr. Mark Charbonnet

What kind of clinician is Dr. Mark Charbonnet?

Dr. Mark Charbonnet is listed as a physician specializing in general practice, also practicing medical oncology.

Where does Dr. Mark Charbonnet practice?

The main practice address at 602 N Lewis St, Suite 600, New Iberia, LA 70563.

What is the NPI number of Dr. Mark Charbonnet?

The National Provider Identifier is 1891718177.

Does Dr. Mark Charbonnet accept Medicare?

Yes. CMS lists this clinician as accepting Medicare assignment. Confirm your plan with the office.

Which hospitals is Dr. Mark Charbonnet affiliated with?

Abbeville General Hospital, Fmol Health Our Lady of Lourdes, Iberia Medical Center.

Where did Dr. Mark Charbonnet go to medical school?

Louisiana State University School of Medicine in New Orleans, graduating in 1996.

Where this information comes from

CMS Doctors and CliniciansName, specialty, education, Medicare enrollment and practice addresses.Centers for Medicare & Medicaid Services, national downloadable file (2026)
NPPES NPI registryNPI, specialties (taxonomy) and state licenses.CMS National Plan and Provider Enumeration System; record updated 2022-01-21
Facility affiliationsHospitals and other facilities.CMS Doctors and Clinicians facility affiliation file; names from CMS Provider of Services
Medicare utilizationPatients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024
MIPSQuality payment program scores.CMS clinician public reporting, PY 2024
Open PaymentsPayments from drug and device companies.CMS Open Payments, program year 2025

Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.

0 clinics selected Compare